EGFR and cholangiocarcinoma: Another selective inhibitor of EGFR, called ZD1839 (IRESSA), was found to stabilize p27Kip1, a cyclin-dependent kinase inhibitor 1B thereby enhancing radiosensitivity in CCA cell lines [191].